Lorella Garofalo

Director of Regulatory Affairs

Pfizer


All Sessions by Lorella Garofalo

Printer Friendly See Full Agenda

Day 1: Oct 6, 2020

9:45 am

9:45 am

Panel Discussion – Streamlining the path to Market:

Regulatory Modernization – Is Canada a Land of Regulatory Obstacles or Opportunities?

The federal government has faced challenges in updating regulations to keep up with the modern changes to drug discovery and with market access. The result could be viewed as onerous regulatory burden or as regulatory clarity paving the way for future opportunities. Take back to your team actionable insights about:

  • The benefits expected from the current federal regulatory modernization project
  • Whether perceived regulatory burdens can be alleviated or reduced
  • How greater clarity in updated regulations can translate into opportunities for market access

Learn how to reduce regulatory burden and leverage regulatory modernization into increased opportunities

Day 2: Oct 7, 2020